Affimed NV Company Profile (NASDAQ:AFMD)

About Affimed NV

Affimed NV logoAffimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its pipeline includes FM13, AFM11, AFM21, AFM22, AFM24, TandAb and Trispecific Abs. It has started recruitment for Phase IIa clinical trial of AFM13 in patients with Hodgkin Lymphoma. It has initiated a Phase I clinical trial of AFM11 in patients with non-Hodgkin Lymphoma. AFM21 is in preclinical development. AFM22, which is an Epidermal Growth Factor Receptor variant III (EGFRvIII)/CD16A NK-cell TandAb is in preclinical development. AFM24 is an additional CD16A NK-cell TandAb targeting a validated solid tumor target, EGFR-wild type. It is developing Trispecific Abs for treating multiple myeloma, and CD33/CD3-specific T-cell TandAb to treat acute myeloid leukemia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AFMD
  • CUSIP:
Key Metrics:
  • Previous Close: $2.00
  • 50 Day Moving Average: $2.04
  • 200 Day Moving Average: $2.31
  • 52-Week Range: $1.65 - $5.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.75
  • P/E Growth: 0.00
  • Market Cap: $66.42M
  • Outstanding Shares: 33,209,000
  • Beta: 3.63
Profitability:
  • Net Margins: -501.31%
  • Return on Equity: -57.35%
  • Return on Assets: -48.29%
Debt:
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 6.27%
  • Quick Ratio: 6.24%
Additional Links:
Companies Related to Affimed NV:

Analyst Ratings

Consensus Ratings for Affimed NV (NASDAQ:AFMD) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $4.33 (116.67% upside)

Analysts' Ratings History for Affimed NV (NASDAQ:AFMD)
Show:
DateFirmActionRatingPrice TargetDetails
11/3/2016Leerink SwannReiterated RatingHold$2.00View Rating Details
8/9/2016Jefferies Group LLCReiterated RatingHoldView Rating Details
5/18/2016Wells Fargo & CompanyReiterated RatingBuyView Rating Details
4/11/2016BMO Capital MarketsInitiated CoverageOutperform$7.00View Rating Details
12/10/2015LaidlawInitiated CoverageBuy$15.00View Rating Details
11/20/2015Oppenheimer Holdings, Inc.Reiterated RatingOutperform$19.00View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Affimed NV (NASDAQ:AFMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2017        
11/2/2016Q316($0.26)($0.31)$2.65 million$0.94 millionViewN/AView Earnings Details
8/10/2016Q216($0.22)($0.24)$2.10 million$2.07 millionViewListenView Earnings Details
5/18/2016Q116($0.17)($0.25)$1.88 million$1.90 millionViewListenView Earnings Details
3/30/2016Q415($0.18)($0.22)$1.71 million$1.66 millionViewListenView Earnings Details
11/10/2015Q315($0.25)($0.24)$1.87 million$1.20 millionViewListenView Earnings Details
8/4/2015Q215($0.14)($0.21)$2.56 million$2.21 millionViewN/AView Earnings Details
5/21/2015Q115($0.14)($0.07)ViewListenView Earnings Details
3/25/2015Q414($0.33)($0.22)ViewN/AView Earnings Details
11/18/2014Q314($0.33)$2.69ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Affimed NV (NASDAQ:AFMD)
Current Year EPS Consensus Estimate: $-1.14 EPS
Next Year EPS Consensus Estimate: $-1.14 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.28)($0.28)($0.28)
Q2 20162($0.29)($0.14)($0.22)
Q3 20162($0.29)($0.23)($0.26)
Q4 20163($0.36)($0.24)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Affimed NV (NASDAQ:AFMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Affimed NV (NASDAQ:AFMD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Affimed NV (NASDAQ:AFMD)
DateHeadline
News IconStock Update: Estimates & Target in Focus for Affimed NV (NASDAQ:AFMD) - Aiken Advocate (NASDAQ:AFMD)
aikenadvocate.com - February 23 at 3:23 PM
News IconAnalysts Peer Into Their Crystal Balls For Affimed NV (NASDAQ:AFMD): Where Is It headed? - Winfield Review (NASDAQ:AFMD)
winfieldreview.com - February 21 at 3:40 PM
investornewswire.com logoAffimed NV (NASDAQ:AFMD) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:AFMD)
www.investornewswire.com - February 20 at 6:18 AM
News IconAffimed NV (NASDAQ:AFMD) Are On Analyst's Buy List - Rives Journal (NASDAQ:AFMD)
rivesjournal.com - February 10 at 3:50 PM
globenewswire.com logoAffimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference - GlobeNewswire (press release) (NASDAQ:AFMD)
www.globenewswire.com - February 8 at 3:27 PM
finance.yahoo.com logoAffimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference (NASDAQ:AFMD)
finance.yahoo.com - February 8 at 3:27 PM
News IconVolatile Stock Causing a Fracas Mid-Session: Affimed NV (NASDAQ:AFMD) - Davidson Register (NASDAQ:AFMD)
davidsonregister.com - February 7 at 1:26 AM
News IconBustling Stock in Focus: Affimed NV (NASDAQ:AFMD) - Aiken Advocate (NASDAQ:AFMD)
aikenadvocate.com - February 6 at 3:25 PM
nasdaq.com logoAffimed (AFMD) Shows Strength: Stock Moves 8.1% Higher - Nasdaq (NASDAQ:AFMD)
www.nasdaq.com - February 6 at 3:25 PM
News IconIs Now the Time to Capitalize on Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - February 1 at 3:15 PM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Affimed N.V. (NASDAQ:AFMD) - Nelson Research (NASDAQ:AFMD)
nelsonobserver.com - February 1 at 1:34 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Affimed NV (NASDAQ:AFMD) - Nelson Research (NASDAQ:AFMD)
nelsonobserver.com - January 31 at 3:31 PM
News IconZeroing in on Company Shares of Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 31 at 3:31 PM
News IconNear-Term, Can This Stock Move the Needle: Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 30 at 8:03 PM
News IconIs This Stock Capable of a Bull Run: Affimed NV (NASDAQ:AFMD) - Nelson Research (NASDAQ:AFMD)
nelsonobserver.com - January 30 at 8:03 PM
News IconAre There Catalysts to Propel This Stock Forward: Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 30 at 8:03 PM
investornewswire.com logoStrong Sell Recommendations Of Affimed N.V. (NASDAQ:AFMD) At 0 - Investor Newswire (NASDAQ:AFMD)
www.investornewswire.com - January 30 at 1:22 AM
News IconWhat are Brokerage Firms Saying About Affimed N.V. (NASDAQ:AFMD)? - Aiken Advocate (NASDAQ:AFMD)
aikenadvocate.com - January 29 at 3:21 PM
News IconRipe for A Big Move? Update on Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 27 at 8:21 PM
realistinvestor.com logoEPS Projection Of Affimed NV (NASDAQ:AFMD) At $-0.13 - RealistInvestor.com (NASDAQ:AFMD)
www.realistinvestor.com - January 27 at 3:21 PM
News IconHigh Volatility Creating Buzz Mid-Session For Affimed N.V. (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 27 at 3:21 PM
globenewswire.com logoAffimed Announces Closing of Public Offering of Common Stock ... - GlobeNewswire (press release) (NASDAQ:AFMD)
www.globenewswire.com - January 26 at 3:36 PM
News IconEarnings in Full Force, Analysts Take Aim at Affimed N.V. (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 26 at 3:36 PM
globenewswire.com logoAffimed Announces Closing of Public Offering of Common Stock - GlobeNewswire (press release) (NASDAQ:AFMD)
globenewswire.com - January 25 at 8:33 PM
finance.yahoo.com logoAffimed Announces Closing of Public Offering of Common Stock (NASDAQ:AFMD)
finance.yahoo.com - January 25 at 8:33 PM
wallstrt24.com logoStocks Buzz FMC Technologies, Inc. (NYSE:FTI), Affimed NV (NASDAQ:AFMD) - Wall Street 24 (NASDAQ:AFMD)
wallstrt24.com - January 25 at 3:27 PM
News IconSteady Activities: Sysco Corporation (NYSE:SYY), Affimed N.V. ... - The Newburgh Press (NASDAQ:AFMD)
newburghpress.com - January 25 at 3:27 PM
finance.yahoo.com logoAffimed Announces Pricing of Public Offering of Common Stock (NASDAQ:AFMD)
finance.yahoo.com - January 20 at 3:28 PM
us.rd.yahoo.com logo4:04 pm Affimed Therapeutics commences an underwritten public offering of its common shares; size not disclosed (NASDAQ:AFMD)
us.rd.yahoo.com - January 19 at 8:44 PM
finance.yahoo.com logoAffimed Announces Proposed Public Offering of Common Stock (NASDAQ:AFMD)
finance.yahoo.com - January 19 at 8:44 PM
News IconPrice Change to Note: Affimed NV Rises A lot Today, Is Now One of The Best Performer - Fair View Times (NASDAQ:AFMD)
fairviewtimes.com - January 18 at 3:53 PM
News IconStock ready to Pivot? Focus on Shares of Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 17 at 3:59 PM
realistinvestor.com logoAffimed NV (NASDAQ:AFMD) EPS Estimate At $-0.13 - RealistInvestor.com (NASDAQ:AFMD)
www.realistinvestor.com - January 14 at 1:44 AM
News IconShares Backsliding in Session: Affimed N.V. (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 12 at 8:26 PM
News IconIs This a Sensible Stock at Current Levels: Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 12 at 8:26 PM
News IconWill The Needle Move For Affimed N.V. (NASDAQ:AFMD) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 12 at 3:25 PM
News IconStock Edging Lower Out Of The Gate: Affimed N.V. (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 12 at 3:25 PM
News IconStock Getting Tripped Up In Session: Affimed N.V. (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 11 at 8:41 PM
News IconCan This Stock Gain Any Traction: Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 11 at 3:40 PM
News IconStock Getting Tripped Up In Session: Affimed NV (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 11 at 3:40 PM
News IconStock Reaching Most Volatile List Today: Affimed N.V. (NASDAQ:AFMD) - Wall Street Beacon (NASDAQ:AFMD)
wsbeacon.com - January 11 at 3:40 PM
streetinsider.com logoAffimed (AFMD) Offers Update on NK-Cell Immuno-Oncology Platform - StreetInsider.com (NASDAQ:AFMD)
www.streetinsider.com - January 11 at 3:40 PM
finance.yahoo.com logoAffimed Provides Update on NK-Cell Immuno-Oncology Platform (NASDAQ:AFMD)
finance.yahoo.com - January 11 at 3:40 PM
News IconKnuckling Down on Shares of Affimed NV (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 10 at 3:15 PM
News IconIs the Needle Ready to Move on Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 9 at 8:23 PM
nasdaq.com logoCan The Uptrend Continue for Affimed N.V. (AFMD)? - Nasdaq (NASDAQ:AFMD)
www.nasdaq.com - January 5 at 8:27 PM
News IconAre Investors Shying Away from Affimed N.V. (NASDAQ:AFMD) - Prospect Journal (NASDAQ:AFMD)
prospectjournal.com - January 5 at 3:27 PM
News IconCan The Uptrend Continue for Affimed N.V. (AFMD)? - Yahoo News (NASDAQ:AFMD)
www.yahoo.com - January 5 at 3:27 PM
finance.yahoo.com logoBlog Coverage Affimed Join Hands with MD Anderson Cancer Center for Clinical Immuno-Oncology Development Collaboration (NASDAQ:AFMD)
finance.yahoo.com - January 5 at 3:27 PM
finance.yahoo.com logoCan The Uptrend Continue for Affimed N.V. (AFMD)? (NASDAQ:AFMD)
finance.yahoo.com - January 5 at 3:27 PM

Social

What is Affimed NV's stock symbol?

Affimed NV trades on the NASDAQ under the ticker symbol "AFMD."

Where is Affimed NV's stock going? Where will Affimed NV's stock price be in 2017?

4 brokers have issued 12 month target prices for Affimed NV's shares. Their predictions range from $2.00 to $7.00. On average, they anticipate Affimed NV's stock price to reach $4.33 in the next twelve months.

When will Affimed NV announce their earnings?

Affimed NV is scheduled to release their next quarterly earnings announcement on Tuesday, March, 28th 2017.

Who owns Affimed NV stock?

Affimed NV's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Orbimed Advisors LLC (10.16%), Bain Capital Public Equity Management LLC (6.32%) and Perceptive Advisors LLC (2.21%).

Who bought Affimed NV stock? Who is buying Affimed NV stock?

Affimed NV's stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC.

How do I buy Affimed NV stock?

Shares of Affimed NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Affimed NV stock cost?

One share of Affimed NV stock can currently be purchased for approximately $2.00.

Affimed NV (NASDAQ:AFMD) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Affimed NV (NASDAQ:AFMD)

Earnings History Chart

Earnings by Quarter for Affimed NV (NASDAQ:AFMD)

Dividend History Chart

Dividend Payments by Quarter for Affimed NV (NASDAQ:AFMD)

Last Updated on 2/24/2017 by MarketBeat.com Staff